Resonetics Acquires EaglePicher’s Medical Power Business

Resonetics has purchased EaglePicher Technologies’ Medical Power business, a manufacturer of implantable batteries for critical medical devices. Neither company disclosed the deal’s terms.

“EaglePicher Medical Power brings another innovative manufacturing capability to Resonetics that will enable our customers to advance the clinical applications requiring miniaturized bioelectronic devices,” said Tom Burns, president and CEO of Resonetics. “We believe integrating this essential battery technology into our core micro manufacturing and sensor capabilities uniquely positions Resonetics as a leading supplier to companies pursuing miniaturized implantable and wearable devices to address unmet clinical needs.”

Based near Vancouver, British Columbia, EaglePicher Medical Power has been designing and manufacturing batteries for medical devices for more than 25 years and produced one of the first lithium-ion cells for an implantable medical device. The Vancouver site features a modern 60,000-square-foot facility with extensive application engineering resources and manufacturing expertise. Chris Huntington, president of EaglePicher Medical Power, will join Resonetics as its chief commercial officer. “I’ve enjoyed leading EaglePicher’s Medical Power division over the last three years, and I look forward to joining Resonetics to support the company’s continued growth in advanced engineering and manufacturing solutions for the life sciences industry,” Huntington said.

“We’re excited to welcome the team in Vancouver to Resonetics and to have Chris Huntington join our senior leadership team,” said Burns. “Chris brings a wealth of MedTech experience gained over the last 20 years in the industry, including leadership positions with Stryker and Symmetry Medical in addition to EaglePicher.” 

Resonetics has completed 11 acquisitions in the past five years and has more than 1,900 employees that operate out of 14 sites located in key medical technology markets with facilities totaling more than 650,000 square feet.
 
“We’ve been able to collaborate with the EaglePicher team and see a lot of synergies. We will invest further in their best-in-class battery solutions by implementing a Lightspeed Application Development Lab for battery solutions to compress development cycles and help our customers reduce their time to market,” added Kevin Hartke, chief technical officer of Resonetics.
 
Founded in 1987, Resonetics develops advanced engineering and manufacturing solutions for the life sciences industry. Resonetics provides laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, microfluidics manufacturing, and sensor technology services. With ten Lightspeed Application Development Labs located strategically to serve medical device companies around the world, is ISO 13485:2016 certified with facilities in the United States, Canada, Costa Rica, Israel, and Switzerland. Resonetics is backed by private equity firms Carlyle and GTCR. 
 
Carlyle is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Global Investment Solutions. Carlyle employs nearly 1,850 people in 26 offices across five continents.
 
Founded in 1980, GTCR is a private equity firm focused on investing in growth companies in the Business and Consumer Services, Financial Services and Technology, Healthcare and Technology, and Media and Telecommunications industries. The Chicago-based firm pioneered The Leaders Strategy— finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $20 billion in over 250 companies.